Showing results (511-520 of 901) with videos related to
Sort By:
Pageof 91
Journal of Oncology Practice|April 14, 2016
Faster FOLFOX: Oxaliplatin Can Be Safely Infused at a Rate of 1 mg/m2/minAndrea Cercek, Vivian Park, Rona Yaeger, et al.Annals of Surgical Oncology|November 5, 2004
Expression of p27 in residual rectal cancer after preoperative chemoradiation predicts long-term outcomeHarvey G Moore, Jinru Shia, David S Klimstra, et al.AMIA Joint Summits on Translational Science Proceedings. AMIA Joint Summits on Translational Science|June 12, 2018
Comparison of Different Classifiers with Active Learning to Support Quality Control in Nucleus Segmentation in Pathology ImagesSi Wen, Tahsin M Kurc, Le Hou, et al.Kidney360|April 4, 2022
Short- and Long-Term Recovery after Moderate/Severe AKI in Patients with and without COVID-19Siao Sun, Raji R Annadi, Imran Chaudhri, et al.Proceedings of the ... International Symposium on High Performance Distributed Computing|November 10, 2011
An Integrated Framework for Parameter-based Optimization of Scientific WorkflowsVijay S Kumar, P Sadayappan, Gaurang Mehta, et al.Pain|June 3, 1999
External validation of IASP diagnostic criteria for Complex Regional Pain Syndrome and proposed research diagnostic criteria. International Association for the Study of PainS Bruehl, R N Harden, B S Galer, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 16, 2001
Phase I study of hepatic arterial infusion of floxuridine and dexamethasone with systemic irinotecan for unresectable hepatic metastases from colorectal cancerN Kemeny, M Gonen, D Sullivan, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2008
Impact of body mass index and weight change after treatment on cancer recurrence and survival in patients with stage III colon cancer: findings from Cancer and Leukemia Group B 89803Jeffrey A Meyerhardt, Donna Niedzwiecki, Donna Hollis, et al.Diseases of the Colon and Rectum|March 20, 2012
FDG-PET assessment of rectal cancer response to neoadjuvant chemoradiotherapy is not associated with long-term prognosis: a prospective evaluationJeannine A Ruby, Tobias Leibold, Timothy J Akhurst, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1996
Neoadjuvant therapy of high-risk gastric cancer: a phase II trial of preoperative FAMTX and postoperative intraperitoneal fluorouracil-cisplatin plus intravenous fluorouracilD Kelsen, M Karpeh, G Schwartz, et al.Pageof 91